Showing results (511-520 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 10, 2010
Lafora disease: epidemiology, pathophysiology and managementThomas S Monaghan, Norman DelantyCNS Drugs|January 25, 2011
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial dataChi-Un Pae, Andy Forbes, Ashwin A PatkarCNS Drugs|January 25, 2011
Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive casesEdward TobinickCNS Drugs|September 16, 2010
Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatmentsMargaret D Weiss, Jay SalpekarCNS Drugs|September 16, 2010
The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic reviewDavid CoghillCNS Drugs|September 16, 2010
Dalfampridine extended release: in multiple sclerosisClaudine M Chwieduk, Gillian M KeatingCNS Drugs|March 24, 2011
Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescentsGillian M KeatingCNS Drugs|May 8, 2019
Buprenorphine Treatment for Opioid Use Disorder: An OverviewMatisyahu Shulman, Jonathan M Wai, Edward V NunesCNS Drugs|May 8, 2019
Correction to: A Multi‑Center, Open‑Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy FemalesYang Xu, Kristin Gabriel, Yi Wang, et al.CNS Drugs|September 21, 2021
Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of SchizophreniaJohn Lauriello, Peter J Weiden, Carole D Gleeson, et al.Pageof 211